Biggest News Aggregation in the World
📰 Mochida News

Mochida News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mochida. Real-time updates on events, politics, business and more.

Ono Pharmaceutical (OTCMKTS:OPHLY) & Amarin (NASDAQ:AMRN) Head to Head Comparison

Amarin (NASDAQ:AMRN – Get Free Report) and Ono Pharmaceutical (OTCMKTS:OPHLY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation. Valuation and Earnings This table compares Amarin and Ono […]
United Arab Emirates United States Mochida Pharmaceutical Co Ltd Turbine Ltd Amarin Corporation Ethical Holdings

Sosei Heptares Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2023

Tokyo, Japan and Cambridge, UK, 10 November 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the third quarter and nine months ended 30 September 2023. The full report can be found by clicking here. Chris Cargill, President & CEO of Sosei Heptares, commented: “The third quarter has been an exciting and transformational period for the Gr...
United Kingdom Soult Ukpyolsi South Korea City Of South Korean Erica Hollingsworth
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 20, 2023 Idorsia Ltd today announced the sale of its operating businesses in the Asia Pacific region , including...
Switzerland General United Kingdom City Of Republic Of South Korea New Zealand

GNW-Adhoc: Idorsia sells its Asia Pacific (ex-China) operations - including select license rights to products - to Sosei Heptares for a total consideration of CHF 400 million

^Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - July 20, 2023 Idorsia Ltd (SIX: IDIA) today announced the sale of its operating businesses in the Asia Pacific (ex-China) region ("Territory"), including assignment of PIVLAZ (clazosentan) and license rights to daridorexant in ...
Switzerland General United Kingdom Republic Of New Zealand South Korea City Of

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science